Flunitrazepam (or ROHYPNOL®) is mainly prescribed to treat severe insomnia.
FDA Approval: (International: AU, UK)
Dosage Forms: 0.5 mg, 1 mg, 2 mg
Biological Half-life: 18-26 hours
Side Effects: Dizziness, sleepiness, blurred vision, anterograde amnesia, slurred speech, confusion, nausea, gastrointestinal disturbances
Precautions: May significantly impair driving or motor skills; used as date rape drug
Routes of Administration: Oral
Pregnancy Category: C (AU)